NDC 42043-390-00 - Granisetron Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42043-390
- Requested NDC
- 42043-390-00
- Package NDCs from labels
- 42043-390-00, 42043-390-02, 42043-390-40, 42043-390-21, 42043-390-20
- Manufacturer
- OrchidPharma Inc | Orchid Pharma Ltd | Orchid Healthcare (a division of Orchid Pharma Ltd)
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Granisetron Hydrochloride | OrchidPharma Inc | Orchid Pharma Ltd | Orchid Healthcare (a division of Orchid Pharma Ltd) | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 42043-390-02 | 2024-12-23 | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e |
| 42043-390-20 | 2024-12-23 | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e |
| 42043-390-21 | 2024-12-23 | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e |
| 42043-390-02 | 2023-07-28 | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e |
| 42043-390-20 | 2023-07-28 | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e |
| 42043-390-21 | 2023-07-28 | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42043-390-00 | EA - Each | 42043-390 | d570196f-b1e1-4e50-a0ca-34bd6768cc2a | 1 | 2016-06-14 |
| 42043-390-02 | EA - Each | 42043-390 | b84db839-f972-4af9-bb36-167222e7269e | 1 | 2016-05-16 |
| 42043-390-20 | EA - Each | 42043-390 | 06ef7fd2-9381-46e9-a7f7-7dff7a674f1b | 1 | 2016-05-16 |
| 42043-390-21 | EA - Each | 42043-390 | 112cf5a3-47e2-41f6-9a22-9ab1174bec63 | 1 | 2016-05-16 |
| 42043-390-40 | EA - Each | 42043-390 | 08d6139d-dce7-407c-9250-e0f257f605cc | 1 | 2016-06-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Eugia US LLC | 783e9d68-2371-4fd4-8d7a-a5e36f8718d0 | 2025-04-24 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisol | GRANISETRON HYDROCHLORIDE | Intra-Sana Laboratories | 2758eb4d-2fe0-4f74-b3f5-b4903009e97c | 2025-03-21 | Warnings, Adverse reactions | 318F6L70J8 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| af5bce26-48c3-4373-8cdc-120e42c2d92f | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e | 2024-12-23 | Warnings, Adverse reactions | bedd0fdd-71e1-4bfa-b577-e04a18a8ea2e | ||
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Breckenridge Pharmaceutical, Inc. | df4b6775-4337-41e0-815a-b064d98c3fe1 | 2024-02-29 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | e07862df-f324-4575-a1ef-f7e1cbab4c7a | 2024-01-04 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Bionpharma Inc. | 50b713d3-7ca8-465a-aefa-65ddbe17b934 | 2023-12-16 | Warnings, Adverse reactions | ANDA078678 318F6L70J8 |
| Granisetron | GRANISETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | dddc8714-383f-4bc5-a468-ae89dbc802b4 | 2022-11-15 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisetron hydrochloride | GRANISETRON HYDROCHLORIDE | Natco Pharma Limited | d2be8de3-04fe-4e92-82b4-98d749b89596 | 2019-10-25 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Mylan Institutional LLC | 8d88adba-7f5e-4e97-84b3-6ca8ec98c023 | 2017-08-31 | Warnings, Adverse reactions | 318F6L70J8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.